Release Date: 12/02/18 08:32 Summary: Takeover Offer - Take No Action Price Sensitive: No Download Document 102.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%